JPH06128141A - External agent for skin - Google Patents

External agent for skin

Info

Publication number
JPH06128141A
JPH06128141A JP4278842A JP27884292A JPH06128141A JP H06128141 A JPH06128141 A JP H06128141A JP 4278842 A JP4278842 A JP 4278842A JP 27884292 A JP27884292 A JP 27884292A JP H06128141 A JPH06128141 A JP H06128141A
Authority
JP
Japan
Prior art keywords
skin
agent
effect
component
asparagus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP4278842A
Other languages
Japanese (ja)
Other versions
JP3105664B2 (en
Inventor
Mariko Muto
真理子 武藤
Ichiro Sasaki
一郎 佐々木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kose Corp
Original Assignee
Kose Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kose Corp filed Critical Kose Corp
Priority to JP04278842A priority Critical patent/JP3105664B2/en
Publication of JPH06128141A publication Critical patent/JPH06128141A/en
Application granted granted Critical
Publication of JP3105664B2 publication Critical patent/JP3105664B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

PURPOSE:To provide an external agent for skin, having excellent active oxygen elimination effect and exhibiting superoxidation preventing effect on lipid, skin aging preventing effect, chapped skin ameliorating effect, etc. CONSTITUTION:The objective agent contains (A) an asparagus extract produced by extracting the stalk, rhizome, leaf, flower, etc., of asparagus with a proper solvent at room temperature or under heating and (B) a superoxide dismutase produced e.g. by extracting the tissue of an animal such as human, cattle or dog or extracting a substance produced by microorganism. The amount of the component A is 0.0001-10wt.%, preferably 0.01-5wt.% (in terms of dried solid component) and that of the component B is 0.00001-5wt.%, preferably 0.001-3wt.%. The external agent for skin may be compounded with conventional external skin agent components such as aqueous component, powder, surfactant, oiliness agent, humectant, alcohol, pH-modifier, antiseptic agent, pigment, antioxidant, ultraviolet absorber, thickener and perfume.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、皮膚外用剤に関し、さ
らに詳しくは、優れた活性酸素除去作用を有し、脂質の
過酸化防止効果、皮膚老化防止効果、肌荒れ改善効果等
を有する化粧品、医薬品等の皮膚外用剤に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an external preparation for skin, more specifically, a cosmetic having an excellent active oxygen removing action, a lipid peroxidation preventing effect, a skin aging preventing effect, a skin roughening improving effect, and the like. The present invention relates to an external preparation for skin such as pharmaceuticals.

【0002】[0002]

【従来の技術】皮膚の老化には、皮膚中での活性酸素の
生成が大きく関わっていることが明らかにされつつあ
る。そこで近年では、皮膚の老化防止の目的で、活性酸
素生成防止剤や活性酸素除去剤、酸化防止剤などが皮膚
外用剤に応用されることが多くなってきた。
2. Description of the Related Art It is becoming clear that the generation of active oxygen in the skin is greatly involved in the aging of the skin. Therefore, in recent years, active oxygen production inhibitors, active oxygen scavengers, antioxidants, and the like have been increasingly applied to external skin preparations for the purpose of preventing skin aging.

【0003】また一方、肌荒れ改善や、皮膚老化防止に
対する薬効成分としては、アラントイン、アロエ抽出
物、人参抽出物、胎盤抽出物、牛血液除蛋白物、発酵代
謝物等が知られている。
On the other hand, allantoin, aloe extract, ginseng extract, placenta extract, bovine blood deproteinate, fermented metabolite and the like are known as medicinal components for improving rough skin and preventing skin aging.

【0004】[0004]

【発明が解決しようとする課題】しかしながら、これら
の薬効成分を配合した皮膚外用剤は、肌荒れ改善や皮膚
老化防止に対して充分な効果を発揮できず、より優れた
細胞賦活作用を有する皮膚外用剤の開発が望まれてい
た。
However, the external preparation for skin containing these medicinal components cannot exert a sufficient effect for improving rough skin and preventing skin aging, and has a superior cell activating effect for external use on the skin. The development of agents was desired.

【0005】[0005]

【課題を解決するための手段】このような実情におい
て、本発明者等は鋭意研究を行なった結果、アスパラガ
ス抽出物とスーパーオキサイドディスムターゼとを併用
することにより、肌荒れ改善作用及び皮膚老化防止作用
に対する効果が相乗的に発揮されることを見出し、本発
明を完成した。
Under such circumstances, the present inventors have conducted diligent research, and as a result, by using an asparagus extract in combination with superoxide dismutase, skin roughening improving action and skin aging preventing action. The present invention has been completed by discovering that the effects on the above are exerted synergistically.

【0006】すなわち、本発明は、(A)アスパラガス
抽出物及び(B)スーパーオキサイドディスムターゼを
含有することを特徴とする皮膚外用剤を提供するもので
ある。
[0006] That is, the present invention provides an external preparation for skin characterized by containing (A) an asparagus extract and (B) a superoxide dismutase.

【0007】本発明の皮膚外用剤に用いるアスパラガス
抽出物とは、アスパラガス(Asparagus of
ficinalis L.)の茎、根茎、葉、花などか
ら抽出して得られるものであり、その調製法は特に限定
されないが、例えば種々の適当な溶媒を用いて室温〜加
温下で抽出される。抽出溶媒としては、例えば水;メチ
ルアルコール、エチルアルコール等の低級一価アルコー
ル;グリセリン、プロピレングリコール、1,3−ブチ
レングリコール等の液状多価アルコール;酢酸エチル等
の低級アルキルエステル;ベンゼン、ヘキサン等の炭化
水素;ジエチルエーテル等のエーテル等の一種又は二種
以上を用いることができる。特に水、エチルアルコー
ル、グリセリン、1,3−ブチレングリコールの一種又
は二種以上の混合溶媒が好ましい。また抽出条件として
は、アスパラガスに対し容量比で1〜1000倍量、特
に5〜100倍量の溶媒を用い、4℃以上、特に15〜
30℃の温度で1時間以上、特に1〜3日間行なうのが
好ましい。
The asparagus extract used in the external preparation for skin of the present invention means asparagus of Asparagus of
ficinalis L .; (3) is obtained by extraction from the stem, rhizome, leaf, flower, etc., and its preparation method is not particularly limited. For example, it is extracted at room temperature to under heating using various suitable solvents. Examples of the extraction solvent include water; lower monohydric alcohols such as methyl alcohol and ethyl alcohol; liquid polyhydric alcohols such as glycerin, propylene glycol and 1,3-butylene glycol; lower alkyl esters such as ethyl acetate; benzene, hexane and the like. The above hydrocarbons; one or more ethers such as diethyl ether can be used. In particular, water, ethyl alcohol, glycerin, and a mixed solvent of one or more kinds of 1,3-butylene glycol are preferable. As the extraction conditions, a solvent is used in a volume ratio of 1 to 1000 times, particularly 5 to 100 times, that of asparagus, at 4 ° C. or higher, particularly 15 to
It is preferable to carry out the treatment at a temperature of 30 ° C. for 1 hour or longer, particularly 1 to 3 days.

【0008】以上のような条件で得られる抽出物は、抽
出された溶液のまま用いても良いが、さらに必要により
濃縮、濾過等の処理をしたものを適宜使い分けて用いる
ことができる。
The extract obtained under the above-mentioned conditions may be used as it is as an extracted solution, but if necessary, it may be subjected to treatments such as concentration and filtration, and used properly.

【0009】本発明の皮膚外用剤におけるアスパラガス
抽出物の配合量は、好ましくは乾燥固形分として0.0
001〜10重量%(以下単に「%」で示す)であり、
好ましくは0.01〜5%である。
The amount of the asparagus extract in the external preparation for skin of the present invention is preferably 0.0 as a dry solid content.
001 to 10% by weight (hereinafter simply referred to as "%"),
It is preferably 0.01 to 5%.

【0010】アスパラガス抽出物の含有量が0.000
1%未満であると効果が充分発揮されず、10.0%を
超えてもそれ以上の効果の増大は見られない。
The content of asparagus extract is 0.000
If it is less than 1%, the effect is not sufficiently exhibited, and if it exceeds 10.0%, the effect is not further increased.

【0011】一方、本発明の他の必須成分である(B)
成分のスーパーオキサイドディスムターゼ(以下、「S
OD」という)は、動物、植物、微生物等の生体内に広
く分布するスーパーオキサイド消去酵素であり、その起
源や取得方法は特に限定されない。
On the other hand, the other essential component of the present invention (B)
Superoxide dismutase (hereinafter referred to as "S
"OD") is a superoxide scavenging enzyme widely distributed in living bodies such as animals, plants and microorganisms, and its origin and acquisition method are not particularly limited.

【0012】このSODの製造方法としては、ヒト、
牛、犬など動物組織から抽出したものでも、キャベツ、
キュウリ、レタスなど植物から抽出したものでも、微生
物が生産したものを抽出したものでもよく、また遺伝子
操作によって製造したものでもよい。さらにSODを主
成分とするものであれば必ずしも精製しなくてもよい。
As a method for producing this SOD, humans,
Even if extracted from animal tissues such as cows and dogs, cabbage,
It may be one extracted from plants such as cucumber and lettuce, one extracted from a microorganism, or one produced by genetic engineering. Furthermore, if it has SOD as a main component, it does not necessarily have to be purified.

【0013】これらSODの本発明皮膚外用剤中の配合
量は、一般には0.00001〜5%、好ましくは0.
001〜3%である。SODの含有量が0.00001
%より少ない場合は、十分な効果が得られないことがあ
り、また、5%を超えて配合してもそれ以上の効果の増
大は見られず、かえって製剤面で悪影響が生じる場合が
ある。
The content of these SODs in the external preparation for skin of the present invention is generally 0.00001 to 5%, preferably 0.
001 to 3%. SOD content is 0.00001
If it is less than 5%, a sufficient effect may not be obtained, and even if it exceeds 5%, the effect may not be further increased, and adversely affect the formulation.

【0014】さらに、本発明の皮膚外用剤には、本発明
の効果を損なわない範囲で、前記必須成分の他、通常の
皮膚外用剤に用いられる水性成分、粉体、界面活性剤、
油剤、保湿剤、アルコール類、pH調整剤、防腐剤、色
素、酸化防止剤、紫外線吸収剤、増粘剤、香料、美容成
分等を必要に応じて適宜配合することができる。
Further, the external preparation for skin of the present invention contains, in the range not impairing the effects of the present invention, the above-mentioned essential components, an aqueous component, a powder, a surfactant, which is used in a general external preparation for skin.
Oil agents, moisturizers, alcohols, pH adjusters, preservatives, pigments, antioxidants, ultraviolet absorbers, thickeners, fragrances, cosmetic ingredients and the like can be appropriately added as necessary.

【0015】本発明の皮膚外用剤は、必須成分の(A)
及び(B)成分を配合し、常法に従って製造することが
できる。そして、乳液、クリーム、化粧水、美容液、ク
レンジング、パック、洗浄料、ファンデーション等や、
その他分散状、顆粒状、軟膏状等の医薬用、医薬部外用
又は化粧用の皮膚外用剤として適用することができる。
The external preparation for skin of the present invention comprises the essential component (A)
And component (B) may be blended to produce the composition according to a conventional method. And emulsion, cream, lotion, beauty essence, cleansing, pack, cleaning agent, foundation, etc.,
In addition, it can be applied as a skin external medicine for dispersion, granule, ointment or the like, for external use for quasi-drugs or for cosmetics.

【0016】[0016]

【実施例】次に、試験例及び実施例を挙げ本発明をさら
に詳しく説明するが、本発明はこれらになんら制約され
るものではない。
EXAMPLES Next, the present invention will be described in more detail with reference to test examples and examples, but the present invention is not limited thereto.

【0017】製造例1(アスパラガス抽出物) 原料として生ホワイトアスパラガス根本部分を2365
0g(新鮮重量として)計量し、次いでアルコール濃度
が60%となるように調整してエタノールを添加した。
これらを食品用ミキサー(ナショナルMX−M3)を用
いて粉砕して、混合物を得た。次いでこれらの原料と溶
媒からなる混合物をポリバケツに入れて、室温下、一昼
夜静置して抽出を行なった後、吸引濾過により抽出液を
吸引濾過ビンに回収した。抽出残渣には再度60%エタ
ノールを25l加え、前述の操作を繰り返した後、抽出
液約66lをロータリーエバポレーターにより濃縮、溶
媒留去して褐色の濃縮抽出物を1000g(乾燥固形分
4%)得た(第1工程)。
Production Example 1 (Asparagus Extract) As a raw material, the raw white asparagus root portion was 2365.
0 g (as fresh weight) was weighed, then adjusted to an alcohol concentration of 60% and ethanol was added.
These were ground using a food mixer (National MX-M3) to obtain a mixture. Then, a mixture consisting of these raw materials and a solvent was placed in a poly bucket, and allowed to stand at room temperature for one day to perform extraction, and then the extract was collected by suction filtration into a suction filtration bottle. To the extraction residue, 25 l of 60% ethanol was added again, and after repeating the above operation, about 66 l of the extract was concentrated by a rotary evaporator and the solvent was distilled off to obtain 1000 g of a brown concentrated extract (dry solid content: 4%). (First step).

【0018】次いで該濃縮抽出物が全て溶解する迄、n
−ブタノールと水(1:1)の混合溶媒を加え、よく振
とうした後、遠心分離機で約1万回転、30分間の遠心
分離を行なって、サポニン成分等をn−ブタノール層に
抽出分離した(第2工程)。次いで該n−ブタノール層
を、ロータリーエバポレーターにより濃縮、溶媒留去し
て約110gの抽出物を得た(第3工程)。
Then, until the concentrated extract is completely dissolved, n
-Add a mixed solvent of butanol and water (1: 1), shake well, and then centrifuge for about 30 minutes with a centrifuge for about 30 minutes to extract and separate saponin components and the like into an n-butanol layer. (Second step). Then, the n-butanol layer was concentrated by a rotary evaporator and the solvent was distilled off to obtain about 110 g of an extract (third step).

【0019】次いで該エキスに水とベンゼンを当量ずつ
加えて懸濁させ、乳白色の溶液を得た。この溶液を遠心
分離機を用いて1万回転、30分間の処理条件で遠心分
離し、分離したベンゼン層を遠心管を傾け上層のベンゼ
ンを捨てるか、或いはピペット管で上層だけを吸い取っ
て取り除くと共に抽出物中の脂質成分の除去を行ない、
さらに残った水層部に、新たなベンゼンを同量加えて同
様な操作を行なった。該脱脂工程は、ベンゼンだけの添
加だけでも良いが、クロロホルムやエーテルのような他
の溶媒を用いると効率良い脱脂が行なえることを確認し
ている(第4工程)。
Next, water and benzene were added to the extract in an equivalent amount and suspended to obtain a milky white solution. This solution was centrifuged at 10,000 rpm for 30 minutes using a centrifuge, and the separated benzene layer was discarded by tilting the centrifuge tube to discard the benzene in the upper layer, or by sucking off only the upper layer with a pipette tube. Removes lipid components from the extract,
The same amount of new benzene was added to the remaining aqueous layer, and the same operation was performed. The degreasing step may be performed by adding only benzene, but it has been confirmed that efficient degreasing can be performed by using another solvent such as chloroform or ether (fourth step).

【0020】次いで得られた水層部分より、ロータリー
エバポレーターによって水分を濃縮、乾固した後、n−
ブタノールと水(1:1)の混合溶媒約1lを添加して
抽出物を溶解させ、分液ロート内で一昼夜静置してサポ
ニン成分をブタノール層に抽出した。次いでブタノール
層を、ロータリーエバポレーターにより濃縮、乾固して
約18gの抽出物(褐色エキス)を得た(第5工程)。
Next, water is concentrated from the obtained water layer portion by a rotary evaporator and dried to dryness, and then n-
About 1 liter of a mixed solvent of butanol and water (1: 1) was added to dissolve the extract, and the saponin component was extracted into the butanol layer by allowing the mixture to stand in a separating funnel for one day. Then, the butanol layer was concentrated by a rotary evaporator and dried to obtain about 18 g of extract (brown extract) (fifth step).

【0021】次いで該褐色抽出物に300mlのメタノー
ルを加えて溶解し、注射針を用いて75mlずつ、別に用
意したエチルエーテル(2l)の中にゆっくり滴下させ
て白色の沈殿を生成せしめ、しばらく静置させた後、傾
潟法によりエーテルを大部分除去し、さらに吸引濾過に
より沈殿を集め、その沈殿物の上から新しいエーテルで
数回洗って、夾雑物の溶けたエーテルを洗い流した。こ
のような操作で得られたほぼ白色の沈殿物を、真空デシ
ケータ中で乾燥した後、乳鉢で粉砕して、約11gのア
スパラガスサボニン粉末を得た(第6工程)。
Then, 300 ml of methanol was added to the brown extract to dissolve it, and 75 ml of each was slowly dropped into a separately prepared ethyl ether (2 l) using an injection needle to form a white precipitate, which was allowed to stand for a while. After leaving it for a long time, most of the ether was removed by the gradient method, the precipitate was collected by suction filtration, and the precipitate was washed with fresh ether several times to wash away the dissolved ether of contaminants. The almost white precipitate obtained by such an operation was dried in a vacuum desiccator and then pulverized in a mortar to obtain about 11 g of asparagus savonin powder (sixth step).

【0022】試験例1 スーパーオキサイド除去活性測定試験:製造例1の第1
工程で得られたアスパラガス抽出物を試料として、下記
測定方法によりスーパーオキサイド除去活性を測定し
た。また、市販のSOD及びこれをアスパラガス抽出物
と組み合わせたものについてもあわせて活性を測定し
た。これらの結果を表1に示す。
Test Example 1 Superoxide removal activity measurement test: No. 1 of Production Example 1
Using the asparagus extract obtained in the step as a sample, the superoxide removing activity was measured by the following measuring method. The activity was also measured for commercially available SOD and a combination thereof with an asparagus extract. The results are shown in Table 1.

【0023】(測定方法)0.05M炭酸ナトリウム緩
衝液(pH10.2)2.4mlに基質溶液〔3.0mMキサ
ンチン(0.05M炭酸ナトリウム緩衝液に溶解)〕
0.1ml、3.0mMEDTA0.1ml、0.15%(W
/V)ウシ血清アルブミン、0.75mMニトロブル−テ
トラゾリウム0.1ml及び各試料0.1mlを混合し、2
5℃で10分間放置した後、酵素溶液〔キサンチンオキ
シダーゼ溶液(精製水にて約0.04units/ml希
釈)〕0.1mlを加えて反応を開始する。25℃で20
分間インキュベートした後、6mM CaCl2 0.1m
lを加えて反応を停止する。次いで560nmにおける吸
光度(A)を測定する。
(Measurement method) A substrate solution in 2.4 ml of 0.05 M sodium carbonate buffer (pH 10.2) [3.0 mM xanthine (dissolved in 0.05 M sodium carbonate buffer)]
0.1 ml, 3.0 mM EDTA 0.1 ml, 0.15% (W
/ V) bovine serum albumin, 0.75 mM nitroblu-tetrazolium 0.1 ml and 0.1 ml of each sample are mixed, and 2
After standing at 5 ° C for 10 minutes, 0.1 ml of an enzyme solution [xanthine oxidase solution (diluted with purified water about 0.04 units / ml)] is added to start the reaction. 20 at 25 ° C
After incubating for 6 minutes, 6mM CaCl 2 0.1m
Stop the reaction by adding l. Then, the absorbance (A) at 560 nm is measured.

【0024】対照には検体のかわりに精製水を加えた試
料の吸光度(B)、また各試料のブランクには、6mM
CaCl2 0.1mlを加えて反応停止後に、キサンチ
ンオキシダーゼ0.1mlを添加した試料の吸光度(C)
を測定し、次式より、スーパーオキサイド除去率を算出
した。
As a control, the absorbance (B) of the sample to which purified water was added instead of the sample, and as a blank for each sample, 6 mM was used.
Absorbance of a sample to which 0.1 ml of xanthine oxidase was added after stopping the reaction by adding 0.1 ml of CaCl 2 (C)
Was measured and the superoxide removal rate was calculated from the following formula.

【0025】[0025]

【数1】 [Equation 1]

【0026】A:試料の酵素反応による吸光度 B:対照の酵素反応による吸光度 C:試料の無酵素反応による吸光度A: Absorbance of sample by enzyme reaction B: Absorbance of control enzyme reaction C: Absorbance of sample without enzyme reaction

【0027】[0027]

【表1】 [Table 1]

【0028】*1:製造例1の第1工程で得られたアス
パラガス抽出物。 *2:シグマ社製;ウシ赤血球より得たもの、3.57
0units/mg
* 1: Asparagus extract obtained in the first step of Production Example 1. * 2: Sigma; obtained from bovine red blood cells, 3.57
0 units / mg

【0029】表1の結果より明らかな如く、アスパラガ
ス抽出物は単独でもSOD様作用を有していたが、SO
Dと併用することにより、相乗的な作用を発揮し、活性
酸素除去に極めて有効であることが示された。
As is clear from the results of Table 1, the asparagus extract alone had an SOD-like action, but SO
It was shown that the combined use with D exerts a synergistic effect and is extremely effective in removing active oxygen.

【0030】このことは、アスパラガス抽出物とSOD
を併用した本発明の皮膚外用剤が、紫外線による皮膚中
での活性酸素生成に起因する過酸化脂質の生成、炎症、
黒化、老化に対し、極めて高い予防効果を有することを
示すものである。
This means that asparagus extract and SOD
The external preparation for skin of the present invention in combination with is the production of lipid peroxide due to the production of active oxygen in the skin by ultraviolet rays, inflammation,
It shows that it has an extremely high preventive effect against blackening and aging.

【0031】実施例1 乳液:表2に示す組成及び下記製法で乳液を調製し、そ
の美肌効果及び皮膚老化防止効果を調べた。この結果を
表5に示す。
Example 1 Emulsion: An emulsion was prepared according to the composition shown in Table 2 and the following production method, and its skin beautifying effect and skin aging preventing effect were examined. The results are shown in Table 5.

【0032】[0032]

【表2】 [Table 2]

【0033】(製法) A.成分(6)、(7)、(9)及び(13)を加熱混
合し、70℃に保つ。 B.成分(1)〜(5)及び(10)を加熱混合し、7
0℃に保つ。 C.BをAに加えて混合し、成分(12)を加えて均一
に乳化し、30℃まで冷却して、成分(8)及び(1
1)を加え、均一に混合して乳液を得る。
(Production Method) A. Ingredients (6), (7), (9) and (13) are heat mixed and maintained at 70 ° C. B. Heat-mix components (1) to (5) and (10),
Keep at 0 ° C. C. B is added to A and mixed, component (12) is added and the mixture is uniformly emulsified, cooled to 30 ° C., and components (8) and (1
1) is added and mixed uniformly to obtain an emulsion.

【0034】(試験方法)28〜58才の女性15名を
パネルとし、毎日、朝と夜の2回、12週間にわたって
洗顔後に被験乳液の適量を顔面に塗布した。塗布による
美肌及び皮膚老化防止効果を下の基準によって評価し
た。
(Test method) Fifteen women aged 28 to 58 were used as a panel, and an appropriate amount of the test emulsion was applied to the face after washing the face twice daily in the morning and at night for 12 weeks. The beautiful skin and anti-aging effect of the application were evaluated according to the following criteria.

【0035】[0035]

【表3】 美肌効果: 〔評 価〕 〔内 容〕 有 効 肌のくすみが目立たなくなった。 やや有効 肌のくすみがあまり目立たなくなった。 無 効 使用前と変化なし。[Table 3] Skin beautifying effect: [Evaluation] [Contents] Effectiveness Dullness of the skin became inconspicuous. Somewhat effective The dullness of the skin became less noticeable. Ineffective No change from before use.

【0036】[0036]

【表4】 皮膚老化防止効果: 〔評 価〕 〔内 容〕 有 効 肌のはり、つやが改善された。 やや有効 肌のはり、つやがやや改善された。 無 効 使用前と変化なし。 (結果)[Table 4] Anti-aging effect on skin: [Evaluation] [Contents] Effectiveness The scalp and gloss of the skin were improved. Slightly effective Skin tone and gloss were slightly improved. Ineffective No change from before use. (result)

【0037】[0037]

【表5】 [Table 5]

【0038】実施例2 クリーム:表6に示す組成及び下記製法でクリームを調
製し、その美肌効果及び皮膚老化防止効果を調べた。こ
の結果を表7に示す。
Example 2 Cream: A cream was prepared by the composition shown in Table 6 and by the following production method, and its skin beautifying effect and skin aging preventing effect were examined. The results are shown in Table 7.

【0039】[0039]

【表6】 [Table 6]

【0040】*3:牛胎盤10kgを細切し、2倍量の5
V/V%エチルアルコール水溶液を加え、37℃で6時
間抽出した後、ゲル濾過、透析などにより精製したも
の。(収量約2kg)タンパク量 約1.0〜1.5% *4:キャベツ1kgを細切し、同量の精製水を加え、ホ
モジナイズする。濾過した後に硫安分画を行ない、透析
処理を行ったもの。(収量約10g)タンパク量 約
2.0〜4.0%
* 3: 10 kg of bovine placenta is finely chopped and doubled to 5
V / V% ethyl alcohol aqueous solution was added, extracted at 37 ° C for 6 hours, and then purified by gel filtration, dialysis and the like. (Yield about 2 kg) Protein amount about 1.0-1.5% * 4: 1 kg of cabbage is cut into small pieces, and the same amount of purified water is added to homogenize. Ammonium sulfate fractionation after filtration and dialysis treatment. (Yield about 10g) Protein amount about 2.0-4.0%

【0041】(製法) A.成分(1)〜(7)、(11)及び(12)を混合
し、加熱して70℃に保つ。 B.成分(8)及び(13)を混合し、加熱して70℃
に保つ。 C.AにBを加え、混合した後、冷却して(9)及び
(10)を加えて、均一に混合して、クリームを得た。 (試験方法)実施例1と同じ (評価基準)実施例1と同じ (結果)
(Production Method) A. Components (1)-(7), (11) and (12) are mixed and heated to maintain 70 ° C. B. Mix components (8) and (13) and heat to 70 ° C.
Keep on. C. After adding B to A, mixing and cooling, (9) and (10) were added and mixed uniformly to obtain a cream. (Test method) Same as Example 1 (Evaluation criteria) Same as Example 1 (Result)

【0042】[0042]

【表7】 [Table 7]

【0043】表7の結果より明らかな如く、本発明品2
及び3のクリームは肌の「つや」や「はり」の喪失、
「くすみ」等の皮膚の老化現象の防止、改善に有効であ
った。
As is clear from the results of Table 7, the product 2 of the present invention
Creams # 3 and # 3 lose the skin's “shine” and “swelling”,
It was effective in preventing and improving skin aging phenomena such as "dullness".

【0044】[0044]

【表8】 実施例3 化粧水: (処方) (%) (1)グリセリン 5.0 (2)1,3−ブチレングリコール 6.5 (3)ポリオキシエチレンソルビタン 1.2 モノラウリン酸エステル(20E.O.) (4)エチルアルコール 8.0 (5)アスパラガス抽出物*1 1.0 (6)SOD*5 0.5 (7)防腐剤 適量 (8)香料 適量 (9)精製水 残量 *5:シグマ社製;人赤血球より得たもの、5.230
units/mg
Table 3 Example 3 Lotion: (Prescription) (%) (1) Glycerin 5.0 (2) 1,3-Butylene glycol 6.5 (3) Polyoxyethylene sorbitan 1.2 Monolaurate (20E) O.) (4) Ethyl alcohol 8.0 (5) Asparagus extract * 1 1.0 (6) SOD * 5 0.5 (7) Preservative proper amount (8) Perfume proper amount (9) Purified water residue Amount * 5: manufactured by Sigma; obtained from human red blood cells, 5.230
units / mg

【0045】(製法) A.成分(3)、(4)、(7)及び(8)を混合溶解
する。 B.成分(1)、(2)、(5)、(6)及び(9)を
混合溶解する。 C.AとBを混合して均一にし、化粧水を得た。
(Production Method) A. Components (3), (4), (7) and (8) are mixed and dissolved. B. Components (1), (2), (5), (6) and (9) are mixed and dissolved. C. A and B were mixed and made uniform to obtain a lotion.

【0046】[0046]

【表9】 実施例4 パック: (処方) (%) (1)ポリビニルアルコール 20.0 (2)エチルアルコール 20.0 (3)グリセリン 5.0 (4)カオリン 6.0 (5)アスパラガス抽出物*1 0.05 (6)SOD含有プラセンタエキス*6 0.01 (7)防腐剤 0.2 (8)香料 0.1 (9)精製水 残量 *6:実施例2のものを凍結乾燥したものTable 4 Example 4 Pack: (Formulation) (%) (1) Polyvinyl alcohol 20.0 (2) Ethyl alcohol 20.0 (3) Glycerin 5.0 (4) Kaolin 6.0 (5) Asparagus Extract * 1 0.05 (6) Placenta extract containing SOD * 6 0.01 (7) Preservative 0.2 (8) Perfume 0.1 (9) Purified water Remainder * 6: Lyophilized

【0047】(製法) A.成分(1)、(3)〜(5)及び(9)を混合し、
70℃に加熱し、撹拌する。 B.成分(2)、(7)及び(8)を混合する。 C.BをAに加え、混合した後、冷却して(6)を均一
に分散してパックを得た。
(Production Method) A. Mixing components (1), (3)-(5) and (9),
Heat to 70 ° C. and stir. B. Mix components (2), (7) and (8). C. B was added to A, mixed, and then cooled to uniformly disperse (6) to obtain a pack.

【0048】[0048]

【表10】 実施例5 洗浄料: (処方) (%) (1)ステアリン酸 10.0 (2)パルミチン酸 8.0 (3)ミリスチン酸 12.0 (4)ラウリン酸 4.0 (5)オレイルアルコール 1.5 (6)精製ラノリン 1.0 (7)香料 0.1 (8)防腐剤 0.2 (9)グリセリン 18.0 (10)水酸化カリウム 6.0 (11)アスパラガス抽出物*1 0.5 (12)SOD*7 0.05 (13)精製水 残量 *7:シグマ社製;ホースラデッシュより得たもの、
2.150units/mg
Table 5 Example 5 Cleaning agent: (Formulation) (%) (1) Stearic acid 10.0 (2) Palmitic acid 8.0 (3) Myristic acid 12.0 (4) Lauric acid 4.0 (5) ) Oleyl alcohol 1.5 (6) Purified lanolin 1.0 (7) Perfume 0.1 (8) Preservative 0.2 (9) Glycerin 18.0 (10) Potassium hydroxide 6.0 (11) Asparagus Extract * 1 0.5 (12) SOD * 7 0.05 (13) Purified water Remainder * 7: Sigma Co .; obtained from Horseradish,
2.150 units / mg

【0049】(製法) A.成分(9)、(10)及び(13)を混合し、70
℃に加熱する。 B.成分(1)〜(6)及び(8)を混合し、70℃に
加熱する。 C.上記Bを先のAに加え、しばらく70℃に保ち、け
ん化反応が終了後、50℃まで冷却し、成分(7)、
(11)及び(12)を加え、冷却して洗浄料を得た。
(Production Method) A. Mixing components (9), (10) and (13), 70
Heat to ℃. B. The components (1) to (6) and (8) are mixed and heated to 70 ° C. C. The above B was added to the above A, kept at 70 ° C. for a while, cooled to 50 ° C. after completion of the saponification reaction, and the component (7),
(11) and (12) were added and cooled to obtain a cleaning agent.

【0050】[0050]

【表11】 実施例6 ゲル軟膏: (処方) (%) (1)カルボキシビニルポリマー 1.0 (2)トリエタノールアミン 1.0 (3)1,3−ブチレングリコール 10.0 (4)アスパラガス抽出物*1 0.01 (5)SOD*7 0.02 (6)精製水 残量Table 11 Example 6 Gel ointment: (formulation) (%) (1) carboxyvinyl polymer 1.0 (2) triethanolamine 1.0 (3) 1,3-butylene glycol 10.0 (4) asparagus Gas extract * 1 0.01 (5) SOD * 7 0.02 (6) Purified water Remaining amount

【0051】(製法) A.成分(1)及び(3)〜(6)を混合溶解する。 B.Aに成分(2)を加え、混合して均一にし、ゲル軟
膏を得た。
(Production Method) A. Components (1) and (3) to (6) are mixed and dissolved. B. Ingredient (2) was added to A, mixed and homogenized to obtain a gel ointment.

【0052】[0052]

【発明の効果】本発明の皮膚外用剤は、優れた活性酸素
除去作用を有するので、肌荒れ改善や、皮膚老化防止等
に安定で且つ優れた効果を有する。従って、本発明の皮
膚外用剤は、紫外線による皮膚中での活性酸素生成に起
因する過酸化脂質の生成、炎症、黒化、老化等に対し、
極めて高い予防効果を有するもので、美容や医療におい
て極めて有用なものである。
EFFECT OF THE INVENTION Since the external preparation for skin of the present invention has an excellent action of removing active oxygen, it has a stable and excellent effect for improving rough skin and preventing skin aging. Therefore, the external preparation for skin of the present invention, for the production of lipid peroxide due to the generation of active oxygen in the skin by ultraviolet rays, inflammation, blackening, aging, etc.,
It has an extremely high preventive effect and is extremely useful in beauty and medicine.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 (A)アスパラガス抽出物及び(B)ス
ーパーオキサイドディスムターゼを含有することを特徴
とする皮膚外用剤。
1. An external preparation for skin comprising (A) an asparagus extract and (B) a superoxide dismutase.
JP04278842A 1992-10-16 1992-10-16 External preparation for skin Expired - Fee Related JP3105664B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP04278842A JP3105664B2 (en) 1992-10-16 1992-10-16 External preparation for skin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP04278842A JP3105664B2 (en) 1992-10-16 1992-10-16 External preparation for skin

Publications (2)

Publication Number Publication Date
JPH06128141A true JPH06128141A (en) 1994-05-10
JP3105664B2 JP3105664B2 (en) 2000-11-06

Family

ID=17602914

Family Applications (1)

Application Number Title Priority Date Filing Date
JP04278842A Expired - Fee Related JP3105664B2 (en) 1992-10-16 1992-10-16 External preparation for skin

Country Status (1)

Country Link
JP (1) JP3105664B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10279458A (en) * 1997-04-01 1998-10-20 Nisshin Oil Mills Ltd:The Composition
JPH10279461A (en) * 1997-04-01 1998-10-20 Nisshin Oil Mills Ltd:The Composition
JP2009298723A (en) * 2008-06-12 2009-12-24 Maruzen Pharmaceut Co Ltd Type iv collagen production promoter

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0729200U (en) * 1993-10-29 1995-06-02 丸井産業株式会社 Concrete top end display for deck plate
JP3086206B2 (en) 1998-07-17 2000-09-11 科学技術振興事業団 Agent learning device

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10279458A (en) * 1997-04-01 1998-10-20 Nisshin Oil Mills Ltd:The Composition
JPH10279461A (en) * 1997-04-01 1998-10-20 Nisshin Oil Mills Ltd:The Composition
JP2009298723A (en) * 2008-06-12 2009-12-24 Maruzen Pharmaceut Co Ltd Type iv collagen production promoter

Also Published As

Publication number Publication date
JP3105664B2 (en) 2000-11-06

Similar Documents

Publication Publication Date Title
JP4918202B2 (en) Skin composition
JPH08283172A (en) Active oxygen scavenger and skin preparation for external use containing the scavenger
JPH07277939A (en) Skin external preparation
JP3170070B2 (en) External preparation for skin
JP3223404B2 (en) Hair restorer
JP2004323406A (en) Humectant, method for using plant extract and external preparation
JP3513872B2 (en) External preparation for skin
JP5765744B2 (en) Preventive or therapeutic agent for atopic dermatitis, and external preparation
JP2008088075A (en) Profilaggrin/filaggrin production promoter, epidermal keratinocyte proliferation promoter, skin care preparation for normalizing epidermis/horny cell layer, profilaggrin/filaggrin production-promoting method and epidermal keratinocyte proliferation-promoting method
JPH04338313A (en) Cosmetic
JP3263409B2 (en) External preparation for skin
JPH0812560A (en) Skin external preparation
JPH08283143A (en) Skin preparation for external use
JP3105664B2 (en) External preparation for skin
JPH1029927A (en) Antiaging agent
JPH1029924A (en) Antiaging agent
JPH06128142A (en) External agent for skin
JPH06128145A (en) External agent for skin
JP3101090B2 (en) External preparation for skin
JPH1160450A (en) Hair tonic
JP2002249438A (en) Age retardant for living organism
JP2002284632A (en) Extinction substance for superoxide anion extracted from sake lees as effective component
JP3480954B2 (en) External preparation for skin
JPH10194982A (en) Collagenase inhibitor and skin lotion for senescence prevention containing the same
JP5000964B2 (en) Testosterone 5α-reductase activity inhibitor, androgen receptor antagonist, use thereof, and method for suppressing androgen activity expression

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110901

Year of fee payment: 11

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120901

Year of fee payment: 12

LAPS Cancellation because of no payment of annual fees